About
Veeva Systems, Inc. engages in the provision of industry cloud solutions for the global life sciences industry. Its solutions enable pharmaceutical and other life sciences companies to realize the benefits of modern cloud-based architectures and mobile applications for their most critical business functions, without compromising industry-specific functionality or regulatory compliance. The firm's customer relationship management solutions enable its customers to increase the productivity and compliance of their sales and marketing functions. Its regulated content management and collaboration solutions enable its customers to more efficiently manage regulated, content-centric processes across the enterprise. The company's customer master solution enables customers to more effectively manage complex healthcare provider and healthcare organization data. The company was founded by Mark Armenante, Peter P. Gassner, Doug Ostler, Mitch Wallace and Matthew J. Wallach on January 12, 2007, and is headquartered in Pleasanton, CA.
Current Value
$216.831 Year Return
Current Value
$216.831 Year Return
Key Details
Market Cap
$36.04B
P/E Ratio
51.15
1Y Stock Return
3.14%
1Y Revenue Growth
16.20%
Dividend Yield
0.00%
Price to Book
6.2
Strategies that include VEEV
Double maintains 15 strategies that include VEEV - Veeva Systems, Inc.
High risk
$1,000
1.09%
Founder Mode
Stocks only get included in this basket, if the companies founders are still actively involved in the company. We equally weight them. Paul Graham talks a bit about Founder Mode in a recent 2024 essay.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
92
High risk
$5,200
0.14%
Growth Stocks
Growth Stocks focuses on companies with strong growth prospects, often found in sectors driving innovation and technological advancement. This ETF invests in companies demonstrating robust revenue and earnings growth, including technology giants, healthcare innovators, and consumer discretionary leaders.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
178
High risk
$1,000
10.00%
Telehealth Growth
The potential benefits from telehealth cover a vast array of areas including virtual care adoption, remote monitoring and diagnostics, digital health infrastructure, and more.
Top Sector
Health Care
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
10
Medium risk
$3,800
0.42%
USA Mid-Cap Companies
Targeting mid-sized U.S. companies, striking a balance between growth potential and stability. Investing in sectors like industrials, technology, consumer goods, and healthcare, it offers exposure to companies with established market positions and growth opportunities.
Top Sector
Industrials
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
316
Medium risk
$14,000
0.59%Health Care Sector
This Strategy focuses on healthcare companies, including pharmaceuticals, biotechnology, healthcare providers, and medical equipment firms. Offering exposure to a sector driven by demographic trends and ongoing medical advancements, it's a strategic choice for investors considering healthcare's long-term growth potential.
Top Sector
Health Care
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
346
Medium risk
$33,000
0.07%
US 1000
This strategy tracks a market-cap-weighted index of the 1000-largest US companies. It offers broad exposure to the US equity market, encompassing a diverse range of sectors and industries. By investing in this fund, you gain access to the performance of large and well-established companies within the US economy.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
1000
Medium risk
$3,400
0.14%
USA Quality Factor
This strategy invests in US large- and mid-cap stocks with a focus on financial quality. Companies are selected and weighted based on their return on equity, earnings growth stability, and financial leverage, emphasizing strong fundamentals. This approach offers investors exposure to companies with proven profitability and sound financial health.
Top Sector
Information Technology
Top Holdings
Bktd. Return
Expense Ratio
0.00%
Holdings
122
High risk
$1,000
1.33%
Stock's related to VEEV
The stocks that are correlated to VEEV - Veeva Systems, Inc. are IQV, S, DOCU, CRL, TECH
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| 46.07% | $29.57B | -29.70% | 0.00% | |
| 43.20% | $5.90B | -18.07% | 0.00% | |
D DOCUDocuSign, Inc. | 43.17% | $15.67B | +31.58% | 0.00% |
| 38.92% | $7.21B | -43.76% | 0.00% | |
T TECHBio-Techne Corp. | 38.90% | $8.67B | -18.18% | 0.61% |
| 38.69% | $1.93B | -44.90% | 0.00% | |
| 37.69% | $713.23M | -72.41% | 0.00% | |
| 37.66% | $1.64B | -43.30% | 0.00% | |
P PHRPhreesia, Inc. | 37.46% | $1.46B | +11.59% | 0.00% |
| 36.87% | $3.04B | -5.88% | 0.00% | |
S SDGRSchrödinger, Inc. | 36.47% | $1.38B | -27.56% | 0.00% |
A ANSSANSYS, Inc. | 36.29% | $27.21B | -9.01% | 0.00% |
P PATHUiPath, Inc. | 35.40% | $5.66B | -51.94% | 0.00% |
A ASANAsana, Inc. | 35.37% | $3.39B | -2.22% | 0.00% |
N NEOGNeogen Corp. | 35.18% | $1.76B | -42.26% | 0.00% |
| 34.94% | $31.27B | -22.41% | 0.92% | |
| 34.71% | $22.29B | -7.59% | 2.55% | |
B BRKRBruker Corp. | 34.69% | $5.71B | -58.05% | 0.56% |
A ARVNArvinas, Inc. | 34.50% | $474.53M | -81.79% | 0.00% |
C CSGPCoStar Group, Inc. | 34.44% | $32.20B | -16.84% | 0.00% |
ETF's related to VEEV
The ETFs that are correlated to VEEV - Veeva Systems, Inc. are ARKG, GNOM, IBB, FBT, RSPA
Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| 47.40% | $987.53M | 0.75% | |
| 45.55% | $48.48M | 0.5% | |
| 45.11% | $5.70B | 0.45% | |
| 43.27% | $1.09B | 0.56% | |
| 43.09% | $294.73M | 0% | |
| 42.77% | $13.48B | 0.47% | |
| 42.65% | $398.68M | 0.45% | |
| 42.62% | $600.30M | 0.15% | |
| 42.20% | $48.65M | 0.69% | |
| 41.73% | $362.92M | 0.35% | |
| 41.43% | $426.00M | 0.65% | |
X XBISPDR Biotech ETF | 41.22% | $5.06B | 0.35% |
| 41.09% | $229.13M | 0.58% | |
| 40.94% | $3.16B | 0.6% | |
| 40.12% | $466.36M | 0.35% | |
| 39.64% | $2.54B | 0.06% | |
| 39.64% | $315.74M | 0.68% | |
| 39.44% | $15.08B | 0.07% | |
| 39.39% | $1.82B | 0.57% | |
| 39.36% | $3.00B | 0.46% | |
News
Yahoo
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, the strategy returned -1.35% (gross) and -1.56% (net) compared to 8.14% for the Russell Midcap Growth Index. In the fourth quarter, the U.S. small […]
Yahoo
Veeva Systems Inc. ( NYSE:VEEV ) recently posted some strong earnings, and the market responded positively. We have...
Yahoo
Veeva introduces a Research Site Clinical Trial Management System to streamline trial operations, enhance collaboration, and accelerate clinical research efficiency.
Yahoo
According to the average brokerage recommendation (ABR), one should invest in Veeva (VEEV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Yahoo
Veeva Systems (NYSE:VEEV) recently announced the launch of Veeva SiteVault CTMS, aiming to enhance clinical trial management efficiency, which coincides with a notable 10% share price increase over the last quarter. The introduction of products like Veeva CRM Pulse, alongside strong Q4 results showing revenue and net income growth, have likely bolstered investor confidence. Despite market volatility due to anticipated U.S. tariffs and mixed general market performance, Veev's sector-specific...
Yahoo
Five stocks have strong momentum for April. These are: APP, MRVL, DOCS, RDDT, VEEV.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
0% Expense Ratios with TLH
We offer over 50 indexes with zero expense ratios.
Registration will take about 10 seconds